Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
Authors
Keywords
-
Journal
BMC GASTROENTEROLOGY
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-13
DOI
10.1186/s12876-021-01773-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PHLPP: a putative cellular target during insulin resistance and type 2 diabetes
- (2017) Alpana Mathur et al. JOURNAL OF ENDOCRINOLOGY
- Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
- (2017) Mary E. Herman et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus
- (2016) S. Gentile et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes mellitus in patients with cirrhosis: clinical implications and management
- (2016) Laure Elkrief et al. LIVER INTERNATIONAL
- Type 2 diabetes: A risk factor for liver mortality and complications in hepatitis B cirrhosis patients
- (2015) John C Hsiang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- New forms of insulin and insulin therapies for the treatment of type 2 diabetes
- (2015) Avivit Cahn et al. Lancet Diabetes & Endocrinology
- Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer
- (2014) S. E. Holden et al. DIABETES OBESITY & METABOLISM
- Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C
- (2014) Laure Elkrief et al. HEPATOLOGY
- Insulin Receptor Signaling in Normal and Insulin-Resistant States
- (2014) J. Boucher et al. Cold Spring Harbor Perspectives in Biology
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Use of Administrative Claims Data for Identifying Patients with Cirrhosis
- (2012) Mahendra S. Nehra et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Diabetes and hypertension: the bad companions
- (2012) Ele Ferrannini et al. LANCET
- Hypoglycemia and Cardiovascular Risks
- (2011) B. M. Frier et al. DIABETES CARE
- All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study
- (2011) Kate M. Fleming et al. LIVER INTERNATIONAL
- Excess Exposure to Insulin Is the Primary Cause of Insulin Resistance and its Associated Atherosclerosis
- (2011) Wenhong Cao et al. Current Molecular Pharmacology
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
- (2009) J.-M. Gamble et al. DIABETES OBESITY & METABOLISM
- Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management
- (2009) Diego Garcia-Compean et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus
- (2009) Valter Donadon et al. Expert Review of Gastroenterology & Hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started